Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi
Gene knockout
Identification
DOI:
10.1126/scisignal.aab3729
Publication Date:
2015-09-08T18:37:57Z
AUTHORS (13)
ABSTRACT
Combining targeted CRISPR-mediated gene editing with an RNAi-mediated screen identifies candidate drug targets.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (126)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....